Back

Dietary lipids attenuate IGF-1-Akt and injure epithelial-endothelial injury program that accelerates obstructive lung disease

Ogasawara, C.; Nohara, H.; Kishimoto, T.; Kawano, K.; Watanabe, K.; Oniki, K.; Fujiwara, Y.; Nakashima, R.; Kamei, S.; Takahashi, N.; Hayashi, M.; Fukuyama, A.; Uemura, M.; Ueno-Shuto, K.; Saruwatari, J.; Otake, K.; Ogata, Y.; Mizukami, Y.; Suico, M. A.; Kai, H.; Shuto, T.

2026-02-01 molecular biology
10.64898/2026.01.29.702619 bioRxiv
Show abstract

Metabolic lipotoxicity injures multiple organs, but its impact on the lung remains unclear. Here we show that a high-fat diet (HFD) accelerates obstructive pathology in {beta}ENaC-transgenic mice and worsens elastase-induced emphysema. Lung transcriptomics reveal repression and rewiring of PI3K-Akt survival circuitry; in both models, phospho-Akt is reduced, FOXO1 is increased, and epithelial apoptosis is induced. Streptozotocin-induced diabetes does not impair lung mechanics, indicating that hyperglycemia or insulin deficiency alone is insufficient. HFD elevates circulating free fatty acids, and palmitate blunts IGF-1-dependent Akt activation in primary human bronchial epithelium. Palmitate also activates endothelium and suppresses junctional genes both directly and via epithelial conditioned media, consistent with epithelial-to-endothelial injury signaling; in vivo, HFD reduces CD34 endothelial cells in susceptible lungs. In men with airflow obstruction, obesity and fatty liver are associated with lower FEV. Together, these findings define pulmonary lipotoxicity as a lipid-driven epithelial-endothelial injury program that accelerates obstructive lung disease.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.